BioLife Solutions Stock News

Stephens Investment Management Group LLC lifted its holdings in shares of BioLife Solutions, Inc. (NASDAQ:BLFS) by 72.6% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 219,059 shares of the medical equipment providers stock after acquiring an additional 92,132 shares during the period. Stephens Investment Management Group LLCs holdings in BioLife Solutions were []

Perkins Capital Management Inc. decreased its position in BioLife Solutions, Inc. (NASDAQ:BLFS) by 4.5% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 21,000 shares of the medical equipment providers stock after selling 1,000 shares during the quarter. Perkins Capital Management Inc. owned []

BioLife Solutions, Inc. (NASDAQ:BLFS) EVP Aby J. Mathew sold 8,853 shares of BioLife Solutions stock in a transaction dated Wednesday, December 8th. The shares were sold at an average price of $36.49, for a total value of $323,045.97. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be []

The Global Biobanking Equipment Market has witnessed continuous growth in the past few years and is projected to grow even further during the forecast period (2021-2028). The research presents a complete assessment of the market and contains Future trend, Current

BioLife Solutions, Inc. (NASDAQ:BLFS)s share price gapped down prior to trading on Monday . The stock had previously closed at $37.12, but opened at $34.14. BioLife Solutions shares last traded at $34.10, with a volume of 1,210 shares traded. BLFS has been the subject of several recent research reports. Cowen boosted their price target on []

Wall Street brokerages expect that BioLife Solutions, Inc. (NASDAQ:BLFS) will post sales of $35.13 million for the current quarter, Zacks Investment Research reports. Five analysts have issued estimates for BioLife Solutions earnings. The highest sales estimate is $36.21 million and the lowest is $34.25 million. BioLife Solutions reported sales of $14.73 million in the same []

Mesirow Financial Investment Management Inc. decreased its position in BioLife Solutions, Inc. (NASDAQ:BLFS) by 19.1% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 11,799 shares of the medical equipment providers stock after selling 2,792 shares during the quarter. BioLife Solutions []

BioLife Solutions, Inc. (NASDAQ:BLFS) insider Karen A. Foster sold 16,332 shares of the firms stock in a transaction on Monday, November 22nd. The stock was sold at an average price of $46.19, for a total transaction of $754,375.08. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through []

BioLife Solutions Inc. (NASDAQ:BLFS) shares, rose in value on Wednesday, 11/24/21, with the stock price down by -3.55% to the previous day’s close as strong demand from buyers drove the stock to $43.95. Actively observing the price movement in the last trading, the stock closed the session at $45.57, falling within a range of $43.56 … BioLife Solutions Inc. (NASDAQ: BLFS) Stock Could Be An Option To Consider Read More »

Equities analysts predict that BioLife Solutions, Inc. (NASDAQ:BLFS) will report sales of $35.13 million for the current quarter, Zacks Investment Research reports. Five analysts have issued estimates for BioLife Solutions earnings, with the lowest sales estimate coming in at $34.25 million and the highest estimate coming in at $36.21 million. BioLife Solutions posted sales of []

BioLife Solutions (NASDAQ:BLFS) was downgraded by Zacks Investment Research from a hold rating to a sell rating in a research report issued on Tuesday, Zacks.com reports. According to Zacks, BioLife Solutions has pioneered the next generation of preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and []

B. Riley reissued their buy rating on shares of BioLife Solutions (NASDAQ:BLFS) in a report published on Thursday, AnalystRatings.com reports. BLFS has been the subject of several other research reports. Zacks Investment Research raised shares of BioLife Solutions from a strong sell rating to a hold rating in a research note on Wednesday, October 13th. []

BioLife Solutions, Inc. (NASDAQ:BLFS)s stock price gapped down before the market opened on Friday after the company announced weaker than expected quarterly earnings. The stock had previously closed at $48.80, but opened at $47.11. BioLife Solutions shares last traded at $45.25, with a volume of 1,695 shares. The medical equipment provider reported ($0.19) earnings per []

BioLife Solutions, Inc. (BLFS) CEO Mike Rise on Q3 2021 Earnings Conference Call -Earnings Call Transcript